JP
Therapeutic Areas
Lucence Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LiquidHALLMARK | Solid Tumors (therapy selection & MRD) | Commercial |
| LucenceINSIGHT | Multi‑cancer early detection (up to 50 cancers) | Commercial |
| LucenceLONGEVITY | Multi‑disease screening (cancer + age‑related diseases) | Commercial |
| UNITED 2.0 | Comprehensive tumor profiling (WES + WTS) | Clinical Development |